R&D Systems™ Recombinant Human LTK Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human LTK Protein is derived from NS0. The Recombinant Human LTK Protein has been validated for the following applications: Bioactivity.

Order Info

Ships at ambient temperature.

Specifications

• Accession Number: P29376-1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Gene ID (Entrez): 4058
• Molecular Weight (g/mol): 42 kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human LTK protein Ser20-Pro424,with a C-terminal His-tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: EC 2.7.10.1, leukocyte receptor tyrosine kinase
• Biological Activity: 40 to 240ng/mL
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining

For Research Use Only.